ABETA Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

ABETA General Information


Developer of diagnostic test-kits for the early detection of Alzheimer's disease. The company develops and markets diagnostic and therapeutic methods for early detection and treatment of neurodegenerative diseases. The company's clinical diagnostic test is based on a system already in use at the ZMBH (Centre for Molecular Biology Heidelberg).

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
The Genetics Company
Primary Office
  • Im Neuenheimer Feld 584
  • 69120 Heidelberg
  • Germany
+49 06221 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ABETA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 16-Jun-2003 Completed Product Development
1. Early Stage VC 01-Jan-2001 Completed Product Development
To view ABETA’s complete valuation and funding history, request access »

ABETA Executive Team (3)

Name Title Board Seat Contact Info
Konrad Beyreuther Founder
Christoph Kronabel Investment Manager
Ulrich Abshagen Investment Manager
To view ABETA’s complete executive team members history, request access »

ABETA Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Heidelberg Innovation Fonds Management Venture Capital Minority 000 0000 000000 0
To view ABETA’s complete investors history, request access »